Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas M Barnes

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
JAMA Psychiatry|March 30, 2022
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders: A Mendelian Randomization StudyJohn A Williams, Stephen Burgess, John Suckling, et al.
Biological Psychiatry Global Open Science|February 6, 2025
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 LevelsFabiana Corsi-Zuelli, Gary Donohoe, Siân Lowri Griffiths, et al.
Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndromeDavid D Manning, Christopher L Cioffi, Alexander Usyatinsky, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
Trials|October 6, 2023
Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trialEdward R Palmer, Siân Lowri Griffiths, Ben Watkins, et al.
Biological Psychiatry|June 1, 2024
Anhedonia as a Potential Transdiagnostic Phenotype With Immune-Related Changes in Recent-Onset Mental Health DisordersParis Alexandros Lalousis, Aanya Malaviya, Ali Khatibi, et al.
Scientific Reports|February 18, 2021
Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulationAlexander Roberts, Lindsay Bentley, Tina Tang, et al.
Biological Psychiatry|June 18, 2022
Neurobiologically Based Stratification of Recent-Onset Depression and Psychosis: Identification of Two Distinct Transdiagnostic PhenotypesParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
JAMA Psychiatry|December 17, 2025
Multivariate Brain-Blood Signatures in Early-Stage Depression and PsychosisDavid Popovic, Clara Weyer, Dominic B Dwyer, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
JAMA Psychiatry|March 30, 2022
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders: A Mendelian Randomization StudyJohn A Williams, Stephen Burgess, John Suckling, et al.
Biological Psychiatry Global Open Science|February 6, 2025
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 LevelsFabiana Corsi-Zuelli, Gary Donohoe, Siân Lowri Griffiths, et al.
Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndromeDavid D Manning, Christopher L Cioffi, Alexander Usyatinsky, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
Trials|October 6, 2023
Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trialEdward R Palmer, Siân Lowri Griffiths, Ben Watkins, et al.
Biological Psychiatry|June 1, 2024
Anhedonia as a Potential Transdiagnostic Phenotype With Immune-Related Changes in Recent-Onset Mental Health DisordersParis Alexandros Lalousis, Aanya Malaviya, Ali Khatibi, et al.
Scientific Reports|February 18, 2021
Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulationAlexander Roberts, Lindsay Bentley, Tina Tang, et al.
Biological Psychiatry|June 18, 2022
Neurobiologically Based Stratification of Recent-Onset Depression and Psychosis: Identification of Two Distinct Transdiagnostic PhenotypesParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
JAMA Psychiatry|December 17, 2025
Multivariate Brain-Blood Signatures in Early-Stage Depression and PsychosisDavid Popovic, Clara Weyer, Dominic B Dwyer, et al.
Pageof 8